This molecule triggers the intrinsic pathway of apoptosis by downregulating Bcl-2, Bcl-xL, survivin, and upregulating Bax, as evidenced in numerous tumor lines of gallbladder cancer, esophageal cancer, colon cancer, leukemia, and glioblastoma [72]. This evidence concerns the gene BCL2L1 and colonic neoplasm.